MedTrace Logo

Accelerated Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LS-SCLC

NCT02990780 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 266

Last updated 2021-04-28

No results posted yet for this study

Summary

This protocol is a phase III randomized controlled trial (RCT) evaluating the efficacy of induction chemotherapy followed by accelerated hypofractionated vs. conventionally fractionated concurrent chemo-radiotherapy for limited-stage small cell lung cancer.

Conditions

Interventions

RADIATION

Conventionally fractionated concurrent chemo-radiotherapy

5Fx/W,2Gy/Fx,Dt:PTV-G:60Gy/30F/6W.

RADIATION

Accelerated hypofractionated concurrent chemo-radiotherapy

5Fx/W,2.5Gy/Fx,Dt:PTV-G:55Gy/22F/4.4W.

Sponsors & Collaborators

  • Shanghai Chest Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02990780 on ClinicalTrials.gov